ヒトマイクロバイオーム市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPBT00002233
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 188
Buy Now

ヒトマイクロバイオーム市場は、2021年の7億1,895万米ドルから2028年までに29億2,168万米ドルに達すると予想されています。 2021 年から 2028 年にかけて 22.2% の CAGR で成長すると推定されています。人間の微生物叢は、各人が保有する何兆もの共生微生物細胞で構成されており、主に腸内の細菌です。細菌、真菌、ウイルスなどの微生物は、時間の経過とともに蓄積する病気の原因物質であり、腸内の生息環境によってその遺伝活動と代謝プロセスが変化し、その結果、通常体内に存在する物質や組織に対する異常な免疫反応が引き起こされます。人体。これらの共生生物が果たす役割と、それらが人間の宿主の健康に及ぼす影響を理解することを目的として、いくつかのマイクロバイオームプロジェクトが世界中で立ち上げられています。ヒトマイクロバイオーム市場の成長は、生活習慣病の発生率の増加、ヒトマイクロバイオーム治療への注目の高まり、メタゲノミクスや次世代シーケンシングにおける技術進歩の高まりなどの要因によるものと考えられています。しかし、政府の厳格なガイドラインと詳細な検査に関する知識の欠如が市場の成長を妨げています。



ヒトマイクロバイオーム市場にとって有利な地域



市場洞察



生活習慣病の発生率の増加



過去数十年で、研究者たちは人間のマイクロバイオームと、がん、糖尿病、肥満、うつ病などの生活習慣病との関係が明らかになりました。ライフスタイルや社会規範の変化は、人生の各段階でマイクロバイオームに影響を与えます。人間のマイクロバイオームを変えることは、そのような生活習慣病の排除に役立ちます。世界保健機関によると、2016 年には世界人口 (成人) の 13% が肥満でした。2016 年に出版された「肥満と代謝性障害の治療の新時代: 腸内マイクロバイオーム移植の証拠と期待」によると、腸内に常在する微生物は人間の消化管では、その組成と機能が肥満の発症に寄与する内分泌器官として機能します。したがって、健康なドナーから患者に糞便を移植する糞便/腸内マイクロバイオーム移植(GMT)は、肥満の治療法となる可能性があります。



糖尿病は、21世紀 世紀の世界的な健康上の緊急事態の 1 つです。国際糖尿病連盟 (IDF) によると、北米で糖尿病に苦しむ人の数は 2017 年に約 4,600 万人でしたが、2045 年までに 6,200 万人に増加すると予想されています。予測期間。ファーミクテス クロストリジウムのレベルの低下は、糖尿病患者の酪酸産生細菌のマイクロバイオームとバクテロイデス:ファーミクテスの比率の増加を示しています。したがって、糖尿病は、プレバイオティクス、プロバイオティクス、および糞便移植の投与によってマイクロバイオームを変化させることによって、予防できるだけでなく治療することもできます。したがって、慢性生活習慣病の発生率の増加がヒトマイクロバイオーム市場の成長を推進しています。



製品ベースの洞察



製品に基づいて、ヒトマイクロバイオーム市場は食品、医療食品に分類されます。 、プロバイオティクス、プレバイオティクス、医薬品、診断機器、サプリメント。プロバイオティクスセグメントは、2021年に最大の市場シェアを保持すると予測されており、プレバイオティクスセグメントは、予測期間中に市場で最高のCAGRを記録すると予想されています。



製品別ヒトマイクロバイオーム市場 - 2021年および2028年



レポートの対象範囲



疾患ベースの洞察



ヒトマイクロバイオーム市場は疾患ごとに、糖尿病、がん、自己免疫疾患、肥満、精神疾患、そして他の病気。がんや糖尿病などの生活習慣病の発生率の増加により、ヒトマイクロバイオームの市場が出現しています。 2021 年には肥満セグメントが市場で最大のシェアを占めると予想されていますが、糖尿病セグメントは予測期間中に最も高い CAGR を記録すると推定されています。



アプリケーションベースの洞察



ヒトマイクロバイオーム市場は、用途別に診断と治療に分類されます。治療薬セグメントは 2021 年にさらに大きな市場シェアを保持すると予測されており、予測期間中にさらに高い CAGR を記録すると推定されています。



戦略的洞察



製品の発売と承認は次のとおりです。企業が世界的な拠点と製品ポートフォリオを拡大するために一般的に採用する戦略。ヒト マイクロバイオーム市場の企業は、顧客層を拡大するためのコラボレーション戦略に焦点を当てており、これにより世界中でブランド名を維持できるようになります。



ヒト マイクロバイオーム市場 – 製品別



< ul>
  • プロバイオティクス

  • 食品

  • プレバイオティクス

  • 医療食品

  • 診断機器

  • 医薬品
  • サプリメント


  • ヒトマイクロバイオーム市場 - 疾患別





    • 肥満

    • 糖尿病

    • 自己免疫障害

    • がん

    • 精神障害

    • その他


    ヒトマイクロバイオーム市場 - アプリケーション別





    • 治療

    • 診断


    ヒトマイクロバイオーム市場 - 地理別





    • 北米

      • 米国
      • カナダ

      • メキシコ



    • ヨーロッパ

      • フランス

      • ドイツ

      • < li>イタリア
      • 英国

      • スペイン

      • ヨーロッパのその他の地域



    • アジア太平洋 (APAC) < ul>
    • 中国

    • インド

    • 韓国

    • 日本

    • オーストラリア

    • その他のアジア太平洋地域



  • 中東およびアフリカ (MEA)

    • 南アフリカ

    • サウジアラビア

    • アラブ首長国連邦
    • その他の中東およびアフリカ



  • 中南米 (SCAM)

    • ブラジル

    • アルゼンチン

    • >
    • その他の中南米




  • 会社概要





    • Rebiotix Inc.

    • >ヤクルト本社株式会社

    • 合成生物製剤株式会社

    • デュポン社

    • MaaT ファーマ

    • エリゴバイオサイエンス

    • < li>Merck & Co. Inc
    • AOBiome LLC

    • Kaleido

    • Seres Therapeutics


    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is the regional analysis in terms of human microbiome market?

    The Asia Pacific human microbiome market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the rest of Asia Pacific. The Asia Pacific region is expected to be the fastest-growing region among all other regions. The rise in the collaborations among the Asian countries and Western countries for the research activities and the extensive genomic research in China are to likely drive the human microbiome market in the forecast period. In May 2018, The Conference on Human Microbiome and Chronic Disease, hosted by the Institute of Microbiology, Chinese Academy of Sciences and Chinese Society of Biotechnology was held in China National Convention Center at Beijing. The aim was to promote research human microbiome and related technology. Thus, there is a huge potential for human microbiome market in the region during the forecast period owing to the above-mentioned factors.

    What are the driving factors for the human microbiome market across the globe?

    The growth of the human microbiome market is attributed to the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies, and growing technological advancements in metagenomics and next-generation sequencing. However strict government guidelines and lack of knowledge about detailed examination hinders the market growth.

    What is human microbiome?

    The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person, mainly bacteria in the gut. The microbes including bacteria, fungi and viruses are the disease-causing microbes that accumulate over time and changing their gene activity & metabolic processes and resulting in an abnormal immune response against the substances and tissues that normally present in the human body.

    The List of Companies - Human Microbiome Market

    1. Rebiotix Inc.
    2. Yakult Honsha Co., Ltd.
    3. Synthetic Biologics Inc.
    4. DuPont
    5. MaaT Pharma
    6. Eligo Bioscience
    7. Merck & Co. Inc
    8. AOBiome LLC
    9. Kaleido
    10. Seres Therapeutics

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports